CRP and breast carcinoma: The observation that several patients among those with an marked elevation of pre-operative CRP level died because of reasons other than breast cancer may suggest that elevated CRP primarily represents the presence of concurrent disease in a small patient subset and is unrelated to primary tumor burden in node-negative breast cancer patients, further supported by the lack of correlation to tumor size and grade.